Filing Details

Accession Number:
0000200406-14-000090
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-25 16:35:14
Reporting Period:
2014-08-21
Filing Date:
2014-08-25
Accepted Time:
2014-08-25 16:35:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1385325 J Dominic Caruso Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick NJ 08933
Vp, Finance; Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-21 30,000 $66.18 91,600 No 4 M Direct
Common Stock Disposition 2014-08-21 30,000 $104.30 61,600 No 4 S Direct
Common Stock Acquisiton 2014-07-31 4 $0.00 72 No 5 J Indirect Johnson & Johnson Stock Fund in the 401(k) plan
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 5 J Indirect Johnson & Johnson Stock Fund in the 401(k) plan
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Deferred Share Units Acquisiton 2014-06-30 168 $0.00 168 $0.00
Common Stock Employee Stock Options (Right to Buy) Disposition 2014-08-21 1,510 $0.00 1,510 $66.18
Common Stock Employee Stock Options (Right to Buy) Disposition 2014-08-21 28,490 $0.00 28,490 $66.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,614 No 4 A Direct
0 2008-02-15 2015-02-13 No 4 M Direct
0 2008-02-15 2015-02-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 225 Indirect ESOP in the 401(k) plan
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $104.30 to $104.305. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  2. Shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2014).
  3. Shares held by ESOP under the Johnson & Johnson Savings Plan as of Plan's most recent reporting date (7/31/2014).
  4. Dividends accrued under the Issuer's Executive Income Deferred Plan. Deferred Share Units are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).
  5. Awarded under Issuer's Stock Option Plan and exercisable in full starting one day after the third anniversary of the grant.